These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 32050773)

  • 21. Multiple defects in energy metabolism in Alzheimer's disease.
    Ferreira IL; Resende R; Ferreiro E; Rego AC; Pereira CF
    Curr Drug Targets; 2010 Oct; 11(10):1193-206. PubMed ID: 20840064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer's Disease and Parkinson's Disease.
    Monzio Compagnoni G; Di Fonzo A; Corti S; Comi GP; Bresolin N; Masliah E
    Mol Neurobiol; 2020 Jul; 57(7):2959-2980. PubMed ID: 32445085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease.
    Swerdlow RH
    Antioxid Redox Signal; 2012 Jun; 16(12):1434-55. PubMed ID: 21902597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer's Disease.
    Cai Q; Tammineni P
    J Alzheimers Dis; 2017; 57(4):1087-1103. PubMed ID: 27767992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic Metabolism and Mitochondria in the Mechanism of Alzheimer's Disease: Finding Potential Therapeutic Targets.
    Song M; Fan X
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of mitochondrial dysfunction in Alzheimer's disease pathogenesis.
    Ashleigh T; Swerdlow RH; Beal MF
    Alzheimers Dement; 2023 Jan; 19(1):333-342. PubMed ID: 35522844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolism: A Novel Shared Link between Diabetes Mellitus and Alzheimer's Disease.
    Sun Y; Ma C; Sun H; Wang H; Peng W; Zhou Z; Wang H; Pi C; Shi Y; He X
    J Diabetes Res; 2020; 2020():4981814. PubMed ID: 32083135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Verapamil attenuates scopolamine induced cognitive deficits by averting oxidative stress and mitochondrial injury - A potential therapeutic agent for Alzheimer's Disease.
    Ponne S; Kumar CR; Boopathy R
    Metab Brain Dis; 2020 Mar; 35(3):503-515. PubMed ID: 31691145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer's disease: A meta-analysis of in vivo magnetic resonance spectroscopy studies.
    Song T; Song X; Zhu C; Patrick R; Skurla M; Santangelo I; Green M; Harper D; Ren B; Forester BP; Öngür D; Du F
    Ageing Res Rev; 2021 Dec; 72():101503. PubMed ID: 34751136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease.
    Zhu X; Perry G; Smith MA; Wang X
    J Alzheimers Dis; 2013; 33 Suppl 1(0 1):S253-62. PubMed ID: 22531428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitochondrial Abeta: a potential cause of metabolic dysfunction in Alzheimer's disease.
    Chen X; Yan SD
    IUBMB Life; 2006 Dec; 58(12):686-94. PubMed ID: 17424907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of cell type-specific mitochondrial dysfunction in the pathogenesis of Alzheimer's disease.
    Kim DK; Mook-Jung I
    BMB Rep; 2019 Dec; 52(12):679-688. PubMed ID: 31722781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomarkers, ketone bodies, and the prevention of Alzheimer's disease.
    VanItallie TB
    Metabolism; 2015 Mar; 64(3 Suppl 1):S51-7. PubMed ID: 25468143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VDAC1, mitochondrial dysfunction, and Alzheimer's disease.
    Shoshan-Barmatz V; Nahon-Crystal E; Shteinfer-Kuzmine A; Gupta R
    Pharmacol Res; 2018 May; 131():87-101. PubMed ID: 29551631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial dysfunction and accumulation of the β-secretase-cleaved C-terminal fragment of APP in Alzheimer's disease transgenic mice.
    Devi L; Ohno M
    Neurobiol Dis; 2012 Jan; 45(1):417-24. PubMed ID: 21933711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early Presymptomatic Changes in the Proteome of Mitochondria-Associated Membrane in the APP/PS1 Mouse Model of Alzheimer's Disease.
    Völgyi K; Badics K; Sialana FJ; Gulyássy P; Udvari EB; Kis V; Drahos L; Lubec G; Kékesi KA; Juhász G
    Mol Neurobiol; 2018 Oct; 55(10):7839-7857. PubMed ID: 29468564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease.
    Yao J; Irwin RW; Zhao L; Nilsen J; Hamilton RT; Brinton RD
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14670-5. PubMed ID: 19667196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic defects shared by Alzheimer's disease and diabetes: A focus on mitochondria.
    Carvalho C; Moreira PI
    Curr Opin Neurobiol; 2023 Apr; 79():102694. PubMed ID: 36842275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting Mitophagy in Alzheimer's Disease.
    Jayatunga DPW; Hone E; Bharadwaj P; Garg M; Verdile G; Guillemin GJ; Martins RN
    J Alzheimers Dis; 2020; 78(4):1273-1297. PubMed ID: 33285629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.